Cargando…

Suppressed Expression of CXCL14 in Hepatocellular Carcinoma Tissues and Its Reduction in the Advanced Stage of Chronic HBV Infection

INTRODUCTION: CXCL14 was a significantly under-expressed mRNA in hepatocellular carcinoma tissues according to our microarray analysis, as well as head and neck squamous cell carcinoma and cervical squamous cell carcinoma. CXCL14 was considered a tumor suppressor in some studies; however, its role i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yong, Chen, Bo-Mei, Yu, Xiao-Lu, Yi, Huo-Chun, Niu, Jian-Jun, Li, Shu-Lian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913250/ https://www.ncbi.nlm.nih.gov/pubmed/31849533 http://dx.doi.org/10.2147/CMAR.S220528

Ejemplares similares

The chemokines CXCL12 and CXCL14 differentially regulate connective tissue markers during limb development
por: Nassari, Sonya, et al.
Publicado: (2017)

Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues
por: Tantiwetrueangdet, Anchalee, et al.
Publicado: (2018)

CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
por: Zajkowska, Monika, et al.
Publicado: (2023)

HBV DNA levels impact the prognosis of hepatocellular carcinoma patients with microvascular invasion
por: Li, Lian, et al.
Publicado: (2019)

Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma
por: Cui, Dawei, et al.
Publicado: (2021)

Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14
por: Cicchini, Louis, et al.
Publicado: (2016)

CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

Profile of HBV Integration in the Plasma DNA of Hepatocellular Carcinoma Patients
por: Li, Weiyang, et al.
Publicado: (2019)

Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection
por: Lin, Yen-Po, et al.
Publicado: (2021)

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
por: Yu, Liang-He, et al.
Publicado: (2011)

Association between the rs9131 and rs3806792 polymorphisms of the CXCL2 gene and the risk of HBV‐related hepatocellular carcinoma in a Guangxi population
por: Lu, Yu, et al.
Publicado: (2020)

CXCL14: the Swiss army knife chemokine
por: Benarafa, Charaf, et al.
Publicado: (2015)

CXCL14 as an emerging immune and inflammatory modulator
por: Lu, Jing, et al.
Publicado: (2016)

Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinoma
por: Mani, Saravana Kumar Kailasam, et al.
Publicado: (2020)

Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
por: Chen, Jian-Lin, et al.
Publicado: (2016)

Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice
por: Hata, Ryu-Ichiro, et al.
Publicado: (2015)

Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma
por: Kondo, T, et al.
Publicado: (2016)

The Intracellular HBV DNAs as Novel and Sensitive Biomarkers for the Clinical Diagnosis of Occult HBV Infection in HBeAg Negative Hepatocellular Carcinoma in China
por: Wang, Hui, et al.
Publicado: (2014)

Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4
por: Collins, Paul J., et al.
Publicado: (2017)

Reduced Incidence of Necrotizing Enterocolitis due to the Anti-Inflammatory Effects of CXCL14 in Intestinal Tissue
por: Sun, Xu, et al.
Publicado: (2022)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma
por: Lin, Selena Y., et al.
Publicado: (2021)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
por: Jiang, Yu, et al.
Publicado: (2021)

Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
por: Meng, Fanping, et al.
Publicado: (2021)

HBV suppresses thapsigargin-induced apoptosis via inhibiting CHOP expression in hepatocellular carcinoma cells
por: Zhao, Danqi, et al.
Publicado: (2017)

CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates
por: Nie, Yuan, et al.
Publicado: (2021)

Retracted: Reduced Incidence of Necrotizing Enterocolitis due to the Anti-Inflammatory Effects of CXCL14 in Intestinal Tissue
por: Healthcare Engineering, Journal of
Publicado: (2023)

Data Mining Suggests That CXCL14 Gene Silencing in Colon Cancer Is Due to Promoter Methylation
por: Wang, Yanjing, et al.
Publicado: (2023)

Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
por: Yoo, Joseph, et al.
Publicado: (2018)

The diagnostic and prognostic implications of PRKRA expression in HBV-related hepatocellular carcinoma
por: Hu, Yi-Min, et al.
Publicado: (2022)

CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
por: Kouzeli, Ariadni, et al.
Publicado: (2020)

Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication
por: Gu, Jin-Gang, et al.
Publicado: (2011)

Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma
por: Hong, Ying-Fen, et al.
Publicado: (2017)

Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy
por: Zhu, Dong-Mei, et al.
Publicado: (2020)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma
por: Wu, Zhong-Jun, et al.
Publicado: (2010)

HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas
por: Yang, Ming, et al.
Publicado: (2020)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
por: Zheng, Ye, et al.
Publicado: (2022)

Mutations in the HBV PreS/S gene related to hepatocellular carcinoma in Vietnamese chronic HBV-infected patients
por: Thi Cam Huong, Nguyen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0mjuao8c4pj0j6gvdap1r7pi17